Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRPEL2 antisense RNA 1 is a noncoding RNA gene annotated in public resources such as GeneCards and Ensembl, distinguished primarily by its transcription from the antisense strand of the GRPEL2 gene locus[1]. It belongs to the lncRNA functional class, but as of this writing, no established biological function, disease association, or therapeutic relevance is available in curated gene/protein databases or the scientific literature. The gene is referenced in databases under external identifiers such as HGNC:48999, NCBI Gene:106144529, and Ensembl:ENSG00000253618[1]. No phenotype, biomarker, or drug–target relationships are documented for GRPEL2-AS1. There is no apparent error or misspelling in the target name itself, but information is sparse, and no evidence indicates that GRPEL2-AS1 is a protein-coding gene, biological receptor, or enzyme. It should not be confused with GRPEL2 (the protein-coding gene for a mitochondrial nucleotide-exchange factor)[3], which is unrelated functionally and structurally. This lncRNA is thus best classified in molecular inventories as: - A long noncoding RNA (lncRNA) antisense to GRPEL2 - Not a classical drug target, receptor, enzyme, transporter, transcription factor, or signaling regulator within current bioinformatics and clinical annotation standards[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRPEL2 antisense RNA 1 (GRPEL2-AS1).